Wedgewood Announces CEO Retirement and Appointment of New CEO
2024年7月3日 - 5:00AM
ビジネスワイヤ(英語)
Wedgewood, the nation’s largest veterinary compounding pharmacy
and a trusted provider of online pharmacy services, announced today
that Marcy Bliss will retire from her role as Chief Executive
Officer. She will retain her position on the Wedgewood Board and
serve as a Senior Advisor to the incoming CEO and Board.
Bliss has been with Wedgewood for 25 years, the last eight as
CEO. She has been an extraordinary leader at Wedgewood, a tireless
defender of veterinary compounding and a fierce advocate for the
rights of animals. During her tenure as CEO, Wedgewood Pharmacy
expanded its operational reach through several significant
acquisitions as well as leading-edge technology with the launch
this year of Blue Rabbit, a next-generation prescription management
platform for veterinarians and their clients.
“It has been a remarkable personal and professional journey to
collaborate alongside the 1,200 dedicated staff at Wedgewood who
tirelessly serve our customers every day,” said Bliss. “It was an
honor and a privilege to work with this team and lead and grow this
company, but the time is right for me to retire. I will miss the
day-to-day of Wedgewood, but I am looking forward to having more
time for family, travel and my commitments to several private
equity Board positions.”
Wedgewood is pleased to announce that Alejandro Bernal, DVM, MS,
MBA, has been named the incoming CEO of Wedgewood Pharmacy. He will
assume this role on July 8.
Bernal is a seasoned Animal Health executive, with global
experience in fast-growing and large-scale businesses in the animal
health and pet care industries for over 25 years. He comes to
Wedgewood most recently from the role of President and CEO of
PetDx®. Prior to that, as President for Mars Veterinary Health
International and Diagnostics, Bernal led the consolidation and
operations of a 700 veterinary hospitals network in Europe and
Asia, and Antech Diagnostics in North America. Prior to joining
Mars Veterinary Health, he spent 18 years at Zoetis (and its
predecessor, Pfizer Animal Health), 10 of them as a member of the
Zoetis Executive Team.
Bernal received his Doctor of Veterinary Medicine (DVM) degree
from Universidad de Caldas in Colombia and earned a Master’s of
Science (MSc) from Texas A&M University. After working as a
veterinarian at a dairy consortium, he earned a Master’s of
Business Administration (MBA) from Universidad de los Andes
(Colombia) and Manchester Business School (U.K.).
“I am honored to be appointed Chief Executive Officer of
Wedgewood Pharmacy,” said Bernal. “As the leader in veterinary
compounding, Wedgewood makes it easy to treat animals with unique
medical needs. I’m inspired by the opportunity to impact the future
of millions of pets and their caregivers with Wedgewood’s products,
services and insights.”
Wedgewood’s business is built on creating relationships with
veterinarians, and the company will leverage Bernal’s background as
a veterinarian and his operational experience in veterinary
services to bring additional insights into improving the lives of
animals and those who love and care for them.
“We are very excited about the future of Wedgewood Pharmacy.
Marcy’s 25-year legacy is an inspiration and on behalf of the
Board, we thank her for her dedicated leadership,” said Kevin
Vasquez, Chairman of the Wedgewood Board. “Marcy is leaving
Wedgewood Pharmacy in a powerful, industry-leading position, and we
are confident that Alejandro will continue to build on that
success. He’s a collaborative and solution-focused leader who will
continue the Company’s commitment to innovation and care for the
health of animals.”
About Wedgewood
Over the last 40 years, Wedgewood has grown from a small,
independent community pharmacy to become the nation’s largest
provider of compounded veterinary medications and clinical pharmacy
services. Our five PCAB®-accredited state-licensed pharmacies and
our two FDA-registered, cGMP 503B outsourcing facilities represent
the gold standard in pharmacy practice, reflecting our unwavering
commitment to quality. The 2023 merger with Blue Rabbit, an
emerging leader in veterinary prescription management and pharmacy
solutions, marks a significant evolution in our services, enabling
us to provide veterinarians with next-generation software and a
wide range of FDA-approved drugs, diets and supplements to
streamline patient care. Together, we serve more than 70,000
veterinary professionals and one million animals annually.
Wedgewood is more than a pharmacy – we are educators, advocates,
partners and solution providers for veterinarians, dedicated to
improving the lives of animals and those who love and care for
them. For more information, visit Wedgewood.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240702622654/en/
For additional information, contact Meg Thomann, Director of
Communications, mthomann@wedgewoodpharmacy.com